Archive

Dive into a collection of past posts and rediscover timeless content.

Goldman Sachs Soars on Q4 Post, Strong Investment Banking Outlook

Jan 20, 2026

•

3 min read

Goldman Sachs Soars on Q4 Post, Strong Investment Banking Outlook

EPS beat despite a revenue hit from the Apple Card transition, while investment‐banking fees and a four‐year high backlog signal continued momentum. CEO David Solomon says M&A optimism under the Trump administration could boost deal activity in 2026.

3 Stocks to Avoid as Software Sector Stumbles

Jan 19, 2026

•

3 min read

3 Stocks to Avoid as Software Sector Stumbles

Agentic AI like Claude Code is automating entire workflows and threatening SaaS license revenue — Salesforce, DocuSign and Atlassian look especially exposed.

Small Caps Break Out! Russell 2000 Poised for 40% Gain

Jan 18, 2026

•

3 min read

Small Caps Break Out! Russell 2000 Poised for 40% Gain

Moderating rates, stronger growth and cheap valuations could propel the Russell 2000 toward a ~40% rally. Stock selection will be critical as many small caps face execution and competition risks.

Amazon Unveils Alexa+ Web—The AI Strategy Wall Street Has Waited For

Jan 17, 2026

•

3 min read

Amazon Unveils Alexa+ Web—The AI Strategy Wall Street Has Waited For

Amazon folds premium AI into Prime and runs it on its own chips, turning Alexa into a sticky, everyday utility. The move boosts pricing power and AWS margins—and gives Wall Street fresh upside to the stock.

Tesla’s Earnings Loom With Almost No Room for Error

Jan 16, 2026

•

3 min read

Tesla’s Earnings Loom With Almost No Room for Error

Analysts are sharply divided as Tesla’s lofty valuation and slowing deliveries leave almost no margin for error; one imperfect quarter could trigger a dramatic re‐pricing. Bulls tout energy, software and robotics upside, while bears warn intensifying competition and weakening fundamentals.

Power Struggle: Why Big Tech Is Buying Nuclear Stocks

Jan 15, 2026

•

3 min read

Power Struggle: Why Big Tech Is Buying Nuclear Stocks

AI’s hunger for 24/7 baseload power is pushing Big Tech into the nuclear fuel chain. From spot-priced uranium bets to tech-backed small modular reactors, investors are racing to secure energy for the next computing boom.

Small Names, Big Impact: The Stocks Behind NVIDIA’s Rubin

Jan 14, 2026

•

1 min read

Small Names, Big Impact: The Stocks Behind NVIDIA’s Rubin

Meet the mid‐ and small‐cap suppliers — power, photonics, packaging and thermal specialists — quietly enabling NVIDIA’s Rubin architecture. These “picks‐and‐shovels” plays could deliver outsized upside where NVIDIA’s sheer size limits returns.

Is It Time to Buy the Dip on Nike and IonQ?

Jan 13, 2026

•

3 min read

Is It Time to Buy the Dip on Nike and IonQ?

Nike’s tariff-hit turnaround and IonQ’s rapid revenue growth present contrasting recovery stories. Here’s what investors should weigh before buying the dip.

This ETF Is Proof That the Healthcare Rebound Is Real

Jan 12, 2026

•

3 min read

This ETF Is Proof That the Healthcare Rebound Is Real

Vanguard’s VHT has surged nearly 19% in six months — a GLP‐1‐fueled, value‐driven rally that could keep healthcare’s momentum going.

This ETF Is Up 146% as the Battle Over Rare Earths Heats Up

Jan 11, 2026

•

3 min read

This ETF Is Up 146% as the Battle Over Rare Earths Heats Up

U.S. policy and rising global demand have propelled rare-earth stocks higher, sending the VanEck REMX ETF soaring. The fund offers diversified, global exposure as countries scramble to secure critical mineral supplies.

Archive

Dive into a collection of past posts and rediscover timeless content.

Goldman Sachs Soars on Q4 Post, Strong Investment Banking Outlook

3 Stocks to Avoid as Software Sector Stumbles

Small Caps Break Out! Russell 2000 Poised for 40% Gain

Amazon Unveils Alexa+ Web—The AI Strategy Wall Street Has Waited For

Tesla’s Earnings Loom With Almost No Room for Error

Power Struggle: Why Big Tech Is Buying Nuclear Stocks

Small Names, Big Impact: The Stocks Behind NVIDIA’s Rubin

Is It Time to Buy the Dip on Nike and IonQ?

This ETF Is Proof That the Healthcare Rebound Is Real

This ETF Is Up 146% as the Battle Over Rare Earths Heats Up

The Markets Daily